Details for New Drug Application (NDA): 215705
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 215705
Tradename: | SUCRALFATE |
Applicant: | Zydus Lifesciences |
Ingredient: | sucralfate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 215705
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCRALFATE | sucralfate | TABLET;ORAL | 215705 | ANDA | REMEDYREPACK INC. | 70518-3959 | 70518-3959-0 | 30 TABLET in 1 BLISTER PACK (70518-3959-0) |
SUCRALFATE | sucralfate | TABLET;ORAL | 215705 | ANDA | Zydus Lifesciences Limited | 70771-1833 | 70771-1833-1 | 100 TABLET in 1 BOTTLE (70771-1833-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | May 3, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription